Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.25.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue $ 4,227 $ 4,129 $ 9,659 $ 12,835
Cost of revenue 1,678 1,920 4,485 6,038
Gross profit 2,549 2,209 5,174 6,797
Operating expenses:        
Sales and marketing 1,313 1,760 4,710 5,424
Research and development 550 777 2,389 3,029
General and administrative 2,088 2,311 6,892 6,574
Total operating expenses 3,951 4,848 13,991 15,027
Loss from operations (1,402) (2,639) (8,817) (8,230)
Other (expense) income, net:        
Interest expense, net (18) (79) (154) (210)
Gain on revaluation of warrant liabilities 0 14 1 440
Loss on modification of warrant 0 0 0 (109)
Unrealized gain on foreign exchange 4 634 1,969 194
Other expense, net (5) (2) (20) (2)
Total other (expense) income, net (19) 567 1,796 313
Net loss (1,421) (2,072) (7,021) (7,917)
Comprehensive loss $ (1,438) $ (2,599) $ (8,678) $ (8,061)
Net loss per share applicable to common stockholders, basic and diluted (in dollars per share) $ (0.54) $ (1.53) $ (3.35) $ (6.37)
Weighted average number of common shares outstanding, basic and diluted (in shares) 2,616 1,354 2,166 1,244
Other comprehensive loss $ (17) $ (527) $ (1,657) $ (144)